Clinical Trial Update: Effect of Preliminary Administration of Cyclosporine (Sandimmun ®) on Different Markers of Cardiac Ischaemia Induced by Cardiopulmonary Bypass [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether preliminary administration of cyclosporine (Sandimmun) affects markers of cardiac ischemia induced by cardiopulmonary bypass in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• Cyclosporine (Sandimmun) (cyclosporine)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Coronary Artery Bypass Surgery, Cardiopulmonary Bypass | Phase 2 | Status: TERMINATED